Literature DB >> 21699981

Nonparametric population modeling and Bayesian analysis.

Roger Jelliffe, Michael Neely, Alan Schumitzky, David Bayard, Michael Van Guilder, Andreas Botnen, Aida Bustad, Derek Laing, Walter Yamada, Jay Bartroff, Tatiana Tatarinova.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21699981     DOI： 10.1016/j.phrs.2011.04.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  5 in total

Review 1.  Opportunities for model-based precision dosing in the treatment of sickle cell anemia.

Authors:  Min Dong; Tomoyuki Mizuno; Alexander A Vinks
Journal:  Blood Cells Mol Dis       Date:  2017-08-09       Impact factor: 3.039

2.  Validation of a pediatric population pharmacokinetic model for vancomycin.

Authors:  Andrea Hahn; Robert W Frenck; Yuanshu Zou; Alexander A Vinks
Journal:  Ther Drug Monit       Date:  2015-06       Impact factor: 3.681

3.  Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.

Authors:  Tianli Wang; Kyle Baron; Wei Zhong; Richard Brundage; William Elmquist
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

4.  Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

Authors:  David A J McDougall; Jennifer Martin; E Geoffrey Playford; Bruce Green
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-12-16       Impact factor: 2.745

5.  Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations.

Authors:  Zhi-Ling Li; Yi-Xi Liu; Zheng Jiao; Gang Qiu; Jian-Quan Huang; Yu-Bo Xiao; Shu-Jin Wu; Chen-Yu Wang; Wen-Juan Hu; Hua-Jun Sun
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.